Elevated levels of interleukin-33 in the nasal secretions of patients with allergic rhinitis

International Archives of Allergy and Immunology

Volumn 158, Issue SUPPL. 1, 2012, Pages 47-50

  Asaka, Daiya ^a   Yoshikawa, Mamoru ^a   Nakayama, Tsuguhisa ^a   Yoshimura, Tsuyoshi ^a   Moriyama, Hiroshi ^a   Otori, Nobuyoshi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Allergic rhinitis; Interleukin 33; Japanese cedar pollinosis; Nasal secretion

Indexed keywords

HOUSE DUST ALLERGEN; INTERLEUKIN 33;

ADULT; ALLERGIC RHINITIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; FEMALE; HUMAN; JAPANESE CEDAR POLLINOSIS; MALE; NOSE SECRETION; PERENNIAL RHINITIS; POLLEN ALLERGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; UPREGULATION;

ADULT; ALLERGENS; ANIMALS; CRYPTOMERIA; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKINS; MALE; MIDDLE AGED; NASAL MUCOSA; POLLEN; PYROGLYPHIDAE; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 84861585129     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000337764     Document Type: Conference Paper

References (21)

1. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ: Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010; 126:466-476.
2. Asher MI, Montefort S, Bjorksten B Lai CK, Strachan DP, Weiland SK, Williams H and ISAAC Phase Three Study Group: Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006; 368:733-743. (Pubitemid 44279052)
3. Okuda M: Epidemiology of Japanese cedar pollinosis throughout Japan. Ann Allergy Asthma Immunol 2003; 91:288-296. (Pubitemid 37174163)
4. Nishima S, Chisaka H, Fujiwara T, Furusho K, Hayashi S, Hiraba K, Kanaya M, Kobayashi N, Kuda N, Kumamoto T, Maeda T, Murayama A, Nagata Y, Narukami H, Nishikawa K, Nishio K, Odajima H, Oka S, Okabe T, Okazaki K, Okazaki T, Okuma M, Ota K, Satomi K, Shimomura M, Suda M, Sunagawa I, Tanaka O, Allergy Prevalence Survey Group, West Japan Pediatric Allergy Association: Surveys on the prevalence of pediatric bronchial asthma in Japan: a comparison between the 1982, 1992, and 2002 surveys conducted in the same region using the same methodol-og y. Allergol Int 2009; 58: 37-53.
5. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479-490. (Pubitemid 41587888)
6. Smith DE: IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin Exp Allergy 2010; 40:200-208. Review.
7. Liew FY, Pitman NI, McInnes IB: Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010; 10: 103-110.
8. Sakashita M, Yoshimoto T, Hirota T, Harada M, Okubo K, Osawa Y, Fujieda S, Nakamura Y, Yasuda K, Nakanishi K, Tamari M: Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis. Clin Exp Allergy 2008; 38: 1875-1881.
9. Onda H, Kasuya H, Takakura K, Hori T, Imaizumi T, Takeuchi T, Inoue I, Takeda J: Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab 1999; 19: 1279-1288. (Pubitemid 30176457)
10. Lüthi AU, Cullen SP, McNeela EA, Duriez PJ, Afonina IS, Sheridan C, Brumatti G, Taylor RC, Kersse K, Vandenabeele P, Lavelle EC, Martin SJ: Suppression of interleukin-33 bio-activity through proteolysis by apoptotic caspases. Immunity 2009; 31:84-98.
11. Okubo K, Gotoh M, Shimada K, Ristu M, Kobayashi M, Okuda M: Effect of fexofena-dine on the quality of life of Japanese cedar pollinosis patients. Allergol Int 2004; 53: 245-254. (Pubitemid 39312320)
12. Okubo K, Gotoh M, Shimada K, Ritsu M, Okuda M, Crawford B: Fexofenadine improves the quality of life and work productiv-it y in Japanese pat ients with seasona l a llergic rhinitis during the peak cedar pollinosis season. Int Arch Allergy Immunol 2005; 136: 148-154. (Pubitemid 40463239)
13. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, von Mutius E, Farrall M, Lathrop M, Cookson WO: GABRIEL Consortium. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010; 363:1211-1221.
14. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT: IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 2007; 117: 1538-1549. (Pubitemid 46871338)
15. Préfontaine D, Nadigel J, Chouiali F, Audus-seau S, Semlali A, Chakir J, Martin JG, Hamid Q: Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 2010; 125: 752-754.
16. Küchler AM, Pollheimer J, Balogh J, Sponheim J, Manley L, Sorensen DR, De Angelis PM, Scott H, Haraldsen G: Nuclear interleu-kin-33 is generally expressed in resting endo-thelium but rapidly lost upon angiogenic or proinflammatory activation. Am J Pathol 2008; 173:1229-1242.
17. Liu YJ: Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006; 203: 269-273.
18. Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, Ishii A, Nambu A, Abe T, Kiyonari H, Matsumoto K, Sudo K, Okumura K, Saito H, Nakae S: IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci USA 2010; 107:18581-18586.
19. Allakhverdi Z, Smith DE, Comeau MR, Delespesse G: Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 2007; 179: 2051-2054.
20. Suzukawa M, Iikura M, Koketsu R, Nagase H, Tamura C, Komiya A, Nakae S, Matsushima K, Ohta K, Yamamoto K, Yamaguchi M: An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J Immunol 2008; 181:5981-5989.
21. Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H: A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol 2008; 121:1484-1490. (Pubitemid 351787349)